A long term, prospective, observational study to evaluate the safety, including cardiovascular safety, of Fremanezumab in patients with migraine in routine clinical practice

by | Mar 16, 2021


To assess the long term safety of fremanezumab and other preventative migraine medications and to assess their effects on the heart and blood vessels

Key Criteria:

▪ adult

▪ migraine diagnosis

▪ no previous CGRP prevention medication use

▪ any new migraine prevention medication start

▪ open to simple monitoring of progress/changes to health on treatment

Join the Study

If you fit the key criteria and are interested in joining the study please email us at research@diamondheadache.com

Discover a Life
Beyond Headache.

Related Posts